Stay updated on Pembrolizumab in NSCLC with PS 2 Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in NSCLC with PS 2 Clinical Trial page.

Latest updates to the Pembrolizumab in NSCLC with PS 2 Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedMinor wording update in the Publications section: 'These publications are provided voluntarily by the person who enters information about the study and are about the results of the study' was changed to improve grammar (Revision: v3.2.0 → v3.3.2); to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedThe page no longer displays the government funding/status notice about potential data delays and operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check42 days agoChange DetectedPosted study results and a related publication have been added. The update includes primary/secondary outcomes, follow-up timelines, and IPD sharing information.SummaryDifference0.5%

- Check71 days agoChange DetectedSummary: The page now displays a funding-status notice and announces a major version upgrade to v3.2.0, replacing the previous v3.1.0.SummaryDifference3%

- Check78 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

- Check93 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab in NSCLC with PS 2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in NSCLC with PS 2 Clinical Trial page.